When does Lonza report earnings and why does it matter for LONN.SW stock?

Lonza reports on **28 Jan 2026**. The print matters because guidance on Biologics, Cell & Gene ramps, and capital spending will drive short-term volatility in LONN.SW stock and influence medium-term valuation.

What valuation should investors monitor for LONN.SW stock?

Focus on trailing PE **53.49**, price-to-sales **5.49**, and free cash flow per share **-3.80**. Improvement in FCF and margin guidance would be the clearest justification for the premium valuation of LONN.SW stock.

How does the sector backdrop affect LONN.SW stock before earnings?

Swiss healthcare is outperforming broader markets; sector PE averages **34.40**. Strong sector flows can help LONN.SW stock, but Lonza must show growth and margin visibility to keep its premium multiple.

What are the most important numbers to watch on the earnings call for LONN.SW stock?

Watch bookings, revenue by division, operating margin guidance, capex outlook, and free cash flow trajectory. Any update that narrows uncertainty could move LONN.SW stock materially.

CH Stocks

CHF555.20 Lonza Group AG (LONN.SW, SIX) intraday before Jan 28 earnings: key metrics to watch

ByDanny Kontos January 23, 2026

We are watching Lonza Group AG (LONN.SW) intraday at CHF555.20 as the company heads into an earnings release on 28 January 2026. The focus keyword LONN.SW stock matters because valuation and volume have started moving ahead of the print. Price is down 0.39% intraday on volume 139,650, slightly above the 30-day average, suggesting traders are positioning for guidance and margin updates.